2Rowe PM. Starve the tumor, save the patient[J]. Lancet, 1997,349 (9045): 108.
3Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis [ J ]. Cell, 1996, 86 (3): 353-364.
4Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothdial cells [ J ].Biochem Biophys Res Commun, 1989,161(2): 851-858.
5Bussolino F, Mantovani A, Persico G. Molecular mechanisms of blood vessel fomation[J]. Trends Biochem Sci, 1997,22(7) :251-256.
6Vincenti V, Cassano C, Rocchi M, et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3[J]. Circulation, 1996,93(8): 1493-1495.
7Brown LF, Detmr M, Claffey K, et al. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine[J]. EXS, 1997,79:233-269.
8Millauer B, Longhi MP, Plate KH, et al. Dominant-negative inhibition of Flk-1 suppresses the growth of many tumor types in vivo[J].Cancer Res, 1996,56(7): 1615-1620.
9Newfeld G, Kesslor 0, Herzog Y. The interaction of neuropilin-1 and neuropilin-2 with tyrosine-kinase receptors for VEGF[J]. Adv Exp Med Biol,2002,515:81-90.
10Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor(VEGF) and its receptors[J]. FASEB J, 1999,13(1):9
